Search PubMed⌕ Search

Biomedical subjects

J Q Feng

Publications and source records attributed to J Q Feng.

32 records · Page 2Linked to original sources

Expression of bone morphogenetic protein messenger RNA in prolonged cultures of fetal rat calvarial cells.

In addition to structural proteins of bone, such as type I collagen, bone cells synthesize a number of growth regulatory peptides that are also stored in the bone matrix, presumably as a consequence of local production by osteoblasts. Among the bone growth regulatory peptides found in the bone matrix are the recently described bone morphogenetic proteins (BMPs). These factors were purified from bone matrix by their capacity to stimulate ectopic bone formation, but it is not known whether they are produced by normal bone cells and influence normal bone formation. To determine whether they are expressed by normal osteoblasts during differentiation, we used the technique of prolonged primary culture of fetal rat calvarial osteoblasts. These cultures have been shown to be an informative model for studying expression of bone-related genes by cultured osteoblasts, since specific genes are expressed as the cells undergo proliferation and differentiation. We found that the bone morphogenetic proteins 1, 2, 4, and 6 are expressed by cultures of fetal rat calvarial osteoblasts before they form mineralized bone nodules and as they express alkaline phosphatase, osteocalcin, and osteopontin. This model can be used for study of regulation of expression of bone morphogenetic proteins by osteoblasts.

Alkaline Phosphatase↗

Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.

Transforming growth factor beta (TGF-beta) is one of the most abundant of the known growth regulatory factors stored within the bone matrix. When bone is resorbed, TGF-beta is released in an active form and is a powerful bone growth stimulant. When injected into the subcutaneous tissue over the calvarial surface of rodents, it rapidly causes proliferation of the periosteal layer and accumulation of new woven bone. In this report, we describe the effects of TGF-beta 1 on first subcultures of fetal rat osteoblasts obtained from calvarial bones and cultured from confluence with ascorbic acid and beta-glycerophosphate. Under these conditions, nodules with characteristics of normal bone appear by day 8. Similar to experiments described by Antosz et al., TGF-beta added to confluent cultures inhibited the formation of bone nodules. Both the number and total area of the nodules were quantitated and shown to be completely inhibited by 2 ng/ml of TGF-beta 1. TGF-beta also impaired the expression of genes associated with bone formation, including type I collagen, alkaline phosphatase, osteopontin, and osteocalcin. TGF-beta also inhibited the expression of mRNA for the bone morphogenetic protein 2 (BMP-2). These results, showing suppression of markers representative of osteoblast differentiation, suggest that the effects of TGF-beta to stimulate bone formation in vivo are not likely a result of effects on differentiated mineralizing osteoblasts but, as suggested by previous studies, more likely are caused by effects on osteoblast precursors. These results also suggest that endogenous BMP-2 expression in fetal rat calvaria cells is important for bone cell differentiation.

Alkaline Phosphatase↗

Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells.

Human prostate cancer cells are known to produce several growth regulatory factors, including transforming growth factor beta (TGF beta) and heparin-binding fibroblast growth factors (FGFs), which may play as-yet-undefined roles in prostate gland morphogenesis, as well as in prostate cancer cell behavior. Recently, a family of proteins in the extended TGF beta family, the bone morphogenetic proteins (BMPs), has been identified which stimulates bone formation in vivo, and in which, the proteins are likely involved in a variety of morphogenetic processes during embryogenesis. These powerful morphogenetic factors are capable of redirecting muscle mesenchyme cells to differentiate along the lines of bone tissue. We examined a number of well-characterized rat and human prostate cancer cell lines for the expression of BMP 2, 3, 4, and 6 messenger RNA. Poly(A+)-RNA was isolated from normal human and rat ventral prostate, from the rat prostate adenocarcinoma PAIII tumor and cultured cells derived from it, and from human prostate cancer cell lines PC-3, LNCaP, and DU-145. BMP mRNA levels were measured using BMP 2, 3, 4 and Vgr-1 (BMP 6) cDNA probes. Both normal and neoplastic prostate tissue expressed these BMP mRNAs, although the level of expression varied from tumor to tumor. Normal human prostate expressed BMP 4 mRNA predominantly, as did the human prostate cancers PC-3 and DU-145. PC-3 also expressed BMP 2 mRNA and BMP 3 mRNA in large amounts. Normal rat ventral prostate expressed all these BMP mRNAs, but the rat prostate adenocarcinoma PAIII expressed predominantly BMP 3 mRNA. The reason that different BMPs are expressed in varying amounts by these normal and neoplastic cells is unknown. However, if these BMPs are expressed in biologically active form, they could be responsible for important effects on normal prostate growth and morphogenesis, on neoplastic prostate cell behavior, and could even contribute to the capacity of prostatic cancer cells to stimulate new bone formation at metastatic tumor sites in bone.

Adenocarcinoma↗

Renal responses to parathyroid hormone in young chickens.

Renal clearance studies were performed in chicks 1, 5, and 9 days after hatching. Calcium gluconate was infused to block endogenous parathyroid hormone (PTH) secretion, whereas ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) was infused to stimulate endogenous PTH secretion. PTH, dibutyryl adenosine 3',5'-cyclic monophosphate (DBcAMP), or vehicle was administered intravenously. In 9-day-old birds, urinary cAMP and inorganic phosphate excretion fell dramatically after calcium loading and rose significantly after PTH, DBcAMP, or EGTA administration. These manipulations had no significant effect on excretion of calcium or inorganic phosphate in 1-day-old hatchlings. Five day-old-chicks gave an intermediate response. All three age groups, as well as 15-day-embryos, showed sharp increases in urinary cAMP values after PTH administration. Thus the adult response pattern to PTH appears to develop gradually during the first week after hatching or to be suppressed during the perinatal period, whereas the second-messenger response to the hormone, indicating hormone-receptor interaction, is present from late embryogenesis onward.

Animals↗

Expression of the BMP 2 gene during bone cell differentiation.

Bone morphogenetic protein 2 (BMP 2) and transforming growth factor beta (TGF beta) are actively involved in bone formation and remodeling. TGF beta, a powerful stimulant in the early stage of bone cell growth and matrix formation, inhibits differentiation and in vitro mineralized nodule formation in primary fetal rat calvarial osteoblast system. TGF beta also negatively regulates BMP 2 expression at the transcriptional level. BMP 2 gene expression is controlled by a battery of transcriptional factors, some known and some yet to be identified. Immortalized osteoblast cell lines generated from a transgenic mouse carrying BMP 2 promoter-driven SV40 large T antigen transgene are described as powerful tools for studying regulation of BMP 2 gene expression and bone cell differentiation at the molecular level.

Animals↗

Cloning and sequence of bone morphogenetic protein 4 cDNA from fetal rat calvarial cell.

A cDNA clone encoding bone morphogenetic protein 4 (BMP 4) has been isolated from a primary fetal rat calvarial cell cDNA library. Sequencing of this clone has revealed a single open reading frame encoding a 408 amino acid protein. Comparison of 5' noncoding exon 1 portion of this cDNA with that of human bone and prostate BMP4 cDNA shows that BMP4 gene expression may possess tissue specificity.

Amino Acid Sequence↗

Renal clearance measurements of electrolytes in embryonic chickens.

Plasma ion concentrations and renal functions were examined in chick embryos after 9, 12, and 15 days of incubation. Plasma calcium and phosphate values rise steadily and significantly between days 9 and 15 of development. Values of other plasma ions (sodium, potassium, magnesium, sulfate) remain more or less the same during this developmental period. Glomerular filtration rates and urine flow rates decline steadily and significantly during this period of embryogenesis when expressed relative to body weight. Renal clearance values of calcium decrease between day 9 (16% of filtered calcium is excreted) and day 15 (4%). The latter value is the same as in birds after hatching and indicates that calcium is being conserved by the kidney of the chick during late embryogenesis. Other ions that appear to be conserved by the embryonic kidney are sodium and sulfate, whereas high percentages of filtered phosphate, potassium, and magnesium are excreted. Except for calcium, there was no significant difference between the renal handling of ions by the mesonephric kidney (functional in 9 day embryos) and the metanephric kidney (predominant in the 15 days embryos).

Analysis of Variance↗

Compartmental analysis and glomerular filtration in chick embryos.

We have developed microtechniques that allow the determination of compartmental fluid distribution and glomerular filtration rate in chick embryos during three significant developmental periods: phase 1, the developmental period when the mesonephros alone is functioning; phase 2, periods of simultaneous meso/metanephric kidney function; and phase 3, the period during late development when the metanephros completely replaces the degenerated mesonephros. Water content of tissues is greater in younger embryos (89.4 +/- 0.2%, day 10) compared with older animals (78.3 +/- 0.5%, day 18). Although all major tissue components show an absolute increase in mass during this period, the embryo proper increases at five times the rate of the extraembryonic tissues. Glomerular filtration rate increases during development from 0.61 +/- 0.08 ml/h at day 10 to 2.31 +/- 0.11 ml/h at day 18. Glomerular filtration rate scales to body mass with an allometric exponent identical to adult birds only if total tissue mass (embryo + membranes) is considered. Our data suggest that significant errors in allometry will be encountered when scaling measurements are made on embryonic or fetal amniotes without taking into consideration the extraembryonic tissues.

Animals↗

[Influence of stimulation of cerebral anterior lateral association area on cortical potentials evoked by C-fiber inputs in saphenous nerve].

The effect of stimulation of cerebral anterior lateral association area (ALA) on evoked potentials recorded in the primary somatosensory cortex (SI), elicited by C-fiber inputs of saphenous nerve (C-CEP) was investigated in cats anesthetized with chloralose and immobilized by Flaxedil. Following 1 min electric stimulation of ALA (0.1 mA, 100 Hz, duration 0.2 ms), the amplitudes of C-CEP were obviously decreased, indicating that ALA had an inhibitory effect on C-CEP. In order to explore the neural pathway underlying the inhibition of C-CEP by ALA stimulation, a vertical section between ALA and SI was made. It was shown that the inhibition of C-CEP produced by ALA stimulation was reduced considerably and the time course of the inhibition was shortened after the section. Moreover, the ALA stimulation-produced inhibition was also blocked partially 7 min after the intraventricular injection of naloxone (25 micrograms/50 microliters). The results suggest that ALA may exert an inhibitory effect on C-CEP, which is mediated by endogenous opiate like substances and through the nervous connection between ALA and SI. The cerebral association area may play a role in the modulation of C-CEP.

Animals↗

Functional differences of six forms of renin in rats.

Six forms of renin with different isoelectric points (pIs) have been described in rats. This study was designed to determine if any of the renin forms have different biological activities. Each form of rat renin was semipurified and injected intravenously or intraventricularly in Sprague-Dawley rats anesthetized with pentobarbital sodium or Inactin. Changes in blood pressure (BP), renal function, sodium, and water excretion were observed, before and following equipressor doses; the peak response of BP was similar for all forms. However, the half-lives were significantly different. Form 4 (pI = 5.2) caused a significant increase in urine flow, Na, and K excretion, and urinary osmolality when given intravenously. The other forms were without significant effect. Infusion of converting enzyme inhibitor not only completely blocked the BP response, but also prevented the natriuresis and diuresis. This was observed in rats anesthetized with pentobarbital sodium or Inactin. Intraventricular infusions resulted in a diuresis and natriuresis when form 6 (pI = 4.8) was infused, but not with other forms. BP remained unchanged throughout. This study presents evidence that functional differences exist between renin forms.

Angiotensin-Converting Enzyme Inhibitors↗

Centrally administered atrial natriuretic factor increases renal water excretion.

The effects of intracerebroventricular (ICV) infusion of atrial natriuretic factor (ANF; atriopeptin III) on renal function, plasma concentrations of antidiurectic hormone, aldosterone, and plasma renin activity (PRA) were examined in anesthetized rats and sodium-depleted conscious sheep. The results were compared with those obtained by intravenous infusion of the same dose of ANF. In both rats and sheep, urine volume was increased four- to sixfold over basal values by ICV infusion of ANF. The response was not associated with increased excretion of sodium or potassium. However, urine osmolality was decreased, and free water clearance increased. Intravenous infusion of the same dose of ANF was without effect. Neither mean arterial blood pressure nor heart rate was changed by the ICV infusion of ANF. In the sheep, renal plasma flow showed no significant changes and glomerular filtration rate was unaltered with the exception of a single experimental period out of four periods of ICV ANF infusion. Plasma concentration of ADH was decreased and PRA increased, whereas aldosterone levels remained unchanged as a function of ICV ANF. In the rat, the diuretic response to ANF was prevented by continuous intravenous infusion of a subpressor dose of ADH. These results suggest that ANF within the central nervous system inhibits secretion of ADH.

Aldosterone↗